These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34728061)

  • 41. Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.
    Wu JH; Marchioli R; Silletta MG; Macchia A; Song X; Siscovick DS; Harris WS; Masson S; Latini R; Albert C; Brown NJ; Lamarra M; Favaloro RR; Mozaffarian D
    J Am Heart Assoc; 2013 Oct; 2(5):e000397. PubMed ID: 24145742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
    Park K; Quesada O; Cook-Wiens G; Wei J; Minissian M; Handberg EM; Merz NB; Pepine CJ
    J Womens Health (Larchmt); 2020 Apr; 29(4):487-492. PubMed ID: 31859580
    [No Abstract]   [Full Text] [Related]  

  • 43. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.
    Fredman G; Serhan CN
    Biochem J; 2011 Jul; 437(2):185-97. PubMed ID: 21711247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of weight loss on neutrophil resolvins in the metabolic syndrome.
    Barden A; Shinde S; Tsai IJ; Croft KD; Beilin LJ; Puddey IB; Mori TA
    Prostaglandins Leukot Essent Fatty Acids; 2019 Sep; 148():25-29. PubMed ID: 31492430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resolvin D1 Reduces Emphysema and Chronic Inflammation.
    Hsiao HM; Thatcher TH; Colas RA; Serhan CN; Phipps RP; Sime PJ
    Am J Pathol; 2015 Dec; 185(12):3189-201. PubMed ID: 26468975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
    Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
    Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging roles of resolvins in the resolution of inflammation and pain.
    Ji RR; Xu ZZ; Strichartz G; Serhan CN
    Trends Neurosci; 2011 Nov; 34(11):599-609. PubMed ID: 21963090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.
    English JT; Norris PC; Hodges RR; Dartt DA; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2017 Feb; 117():17-27. PubMed ID: 28237084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study.
    Berge RK; Ramsvik MS; Bohov P; Svardal A; Nordrehaug JE; Rostrup E; Bruheim I; Bjørndal B
    Lipids Health Dis; 2015 Dec; 14():163. PubMed ID: 26666303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement.
    Sarter B; Kelsey KS; Schwartz TA; Harris WS
    Clin Nutr; 2015 Apr; 34(2):212-8. PubMed ID: 24679552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.
    Marchand NE; Choi MY; Oakes EG; Cook NR; Stevens E; Gomelskaya N; Kotler G; Manson JE; Lasky-Su J; Mora S; Lee IM; Tatituri R; Costenbader KH
    Prostaglandins Leukot Essent Fatty Acids; 2023 Mar; 190():102542. PubMed ID: 36773395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
    Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
    Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.
    Kwon Y
    Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    Jones E; Wei J; Nelson MD; Bakir M; Mehta PK; Shufelt C; Minissian M; Sharif B; Pepine CJ; Handberg E; Cook-Wiens G; Sopko G; Bairey Merz CN
    PLoS One; 2020; 15(12):e0243213. PubMed ID: 33270715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.
    Serhan CN; Yang R; Martinod K; Kasuga K; Pillai PS; Porter TF; Oh SF; Spite M
    J Exp Med; 2009 Jan; 206(1):15-23. PubMed ID: 19103881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pre-eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma.
    Oliveira Perucci L; Pereira Santos TA; Campi Santos P; Ribeiro Teixeira LC; Nessralla Alpoim P; Braga Gomes K; Pires Sousa L; Sant'Ana Dusse LM; Talvani A
    Am J Reprod Immunol; 2020 Feb; 83(2):e13206. PubMed ID: 31679164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
    Tamarappoo B; Samuel TJ; Elboudwarej O; Thomson LEJ; Aldiwani H; Wei J; Mehta P; Cheng S; Sharif B; AlBadri A; Handberg EM; Petersen J; Pepine CJ; Nelson MD; Bairey Merz CN
    Int J Cardiol; 2021 Mar; 327():25-30. PubMed ID: 33202262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathway Markers for Pro-resolving Lipid Mediators in Maternal and Umbilical Cord Blood: A Secondary Analysis of the Mothers, Omega-3, and Mental Health Study.
    Mozurkewich EL; Greenwood M; Clinton C; Berman D; Romero V; Djuric Z; Qualls C; Gronert K
    Front Pharmacol; 2016; 7():274. PubMed ID: 27656142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial.
    Handberg EM; Merz CNB; Cooper-Dehoff RM; Wei J; Conlon M; Lo MC; Boden W; Frayne SM; Villines T; Spertus JA; Weintraub W; O'Malley P; Chaitman B; Shaw LJ; Budoff M; Rogatko A; Pepine CJ
    Am Heart J; 2021 Jul; 237():90-103. PubMed ID: 33745898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619.
    Jannaway M; Torrens C; Warner JA; Sampson AP
    Br J Pharmacol; 2018 Apr; 175(7):1100-1108. PubMed ID: 29352769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.